Originally published by our sister publication Pain Medicine News
The FDA announced major changes to its opioid pain medication labeling regulations that better emphasize and explain the risks of using the medications over long periods of time.
The July 31 announcement came after a public advisory committee meeting in May where experts reviewed the data showing the risks for misuse, addiction, and both fatal and nonfatal overdoses for patients treated with opioids for longer periods.
The